Barclays PLC Sells 4,035 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Barclays PLC lessened its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 1.6% in the 4th quarter, Holdings Channel reports. The firm owned 244,423 shares of the biopharmaceutical company’s stock after selling 4,035 shares during the period. Barclays PLC’s holdings in Catalyst Pharmaceuticals were worth $5,101,000 at the end of the most recent […]
Barclays PLC lessened its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 1.6% in the 4th quarter, Holdings Channel reports. The firm owned 244,423 shares of the biopharmaceutical company’s stock after selling 4,035 shares during the period. Barclays PLC’s holdings in Catalyst Pharmaceuticals were worth $5,101,000 at the end of the most recent […]
